Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9)

Jacqulyne P. Robichaux; Yasir Y. Elamin; Zhi Tan; Brett W. Carter; Shuxing Zhang; Shengwu Liu; Shuai Li; Ting Chen; Alissa Poteete; Adriana Estrada-Bernal; Anh T. Le; Anna Truini; Monique B. Nilsson; Huiying Sun; Emily Roarty; Sarah B. Goldberg; Julie R. Brahmer; Mehmet Altan; Charles Lu; Vassiliki Papadimitrakopoulou; Katerina Politi; Robert C. Doebele; Kwok Kin Wong; John V. Heymach

doi:10.1038/s41591-024-03178-1

Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9)

Jacqulyne P. Robichaux, Yasir Y. Elamin, Zhi Tan, Brett W. Carter, Shuxing Zhang, Shengwu Liu, Shuai Li, Ting Chen, Alissa Poteete, Adriana Estrada-Bernal, Anh T. Le, Anna Truini, Monique B. Nilsson, Huiying Sun, Emily Roarty, Sarah B. Goldberg, Julie R. Brahmer, Mehmet Altan, Charles Lu, Vassiliki PapadimitrakopoulouKaterina Politi, Robert C. Doebele, Kwok Kin Wong, John V. Heymach

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-018-0007-9, published online 23 April 2018. In the version of the article initially published, in Supplementary Fig. 7c, the ERK1/2 blot (afatinib treatment) was flipped with respect to the drug concentration. The corrected version is shown below as Fig. 1. The blots shown in Supplementary Fig. 10d were a repeat of the experiment and have now been corrected to show the membranes that correspond to Supplementary Fig. 7c. The corrected figure is shown below as Fig. 2. (Figure presented.) (Figure presented.)

Original language	English (US)
Pages (from-to)	2694-2695
Number of pages	2
Journal	Nature medicine
Volume	30
Issue number	9
DOIs	https://doi.org/10.1038/s41591-024-03178-1
State	Published - Sep 2024

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1038/s41591-024-03178-1

Fingerprint

Dive into the research topics of 'Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9)'. Together they form a unique fingerprint.

Cite this

Robichaux, J. P., Elamin, Y. Y., Tan, Z., Carter, B. W., Zhang, S., Liu, S., Li, S., Chen, T., Poteete, A., Estrada-Bernal, A., Le, A. T., Truini, A., Nilsson, M. B., Sun, H., Roarty, E., Goldberg, S. B., Brahmer, J. R., Altan, M., Lu, C., ... Heymach, J. V. (2024). Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9). Nature medicine, 30(9), 2694-2695. https://doi.org/10.1038/s41591-024-03178-1

Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9). / Robichaux, Jacqulyne P.; Elamin, Yasir Y.; Tan, Zhi et al.
In: Nature medicine, Vol. 30, No. 9, 09.2024, p. 2694-2695.

Research output: Contribution to journal › Comment/debate › peer-review

Robichaux, JP, Elamin, YY, Tan, Z, Carter, BW, Zhang, S, Liu, S, Li, S, Chen, T, Poteete, A, Estrada-Bernal, A, Le, AT, Truini, A, Nilsson, MB, Sun, H, Roarty, E, Goldberg, SB, Brahmer, JR, Altan, M, Lu, C, Papadimitrakopoulou, V, Politi, K, Doebele, RC, Wong, KK & Heymach, JV 2024, 'Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9)', Nature medicine, vol. 30, no. 9, pp. 2694-2695. https://doi.org/10.1038/s41591-024-03178-1

@article{bc427802b0ab4d3b9db744f254b693c2,

title = "Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9)",

abstract = "Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-018-0007-9, published online 23 April 2018. In the version of the article initially published, in Supplementary Fig. 7c, the ERK1/2 blot (afatinib treatment) was flipped with respect to the drug concentration. The corrected version is shown below as Fig. 1. The blots shown in Supplementary Fig. 10d were a repeat of the experiment and have now been corrected to show the membranes that correspond to Supplementary Fig. 7c. The corrected figure is shown below as Fig. 2. (Figure presented.) (Figure presented.)",

author = "Robichaux, {Jacqulyne P.} and Elamin, {Yasir Y.} and Zhi Tan and Carter, {Brett W.} and Shuxing Zhang and Shengwu Liu and Shuai Li and Ting Chen and Alissa Poteete and Adriana Estrada-Bernal and Le, {Anh T.} and Anna Truini and Nilsson, {Monique B.} and Huiying Sun and Emily Roarty and Goldberg, {Sarah B.} and Brahmer, {Julie R.} and Mehmet Altan and Charles Lu and Vassiliki Papadimitrakopoulou and Katerina Politi and Doebele, {Robert C.} and Wong, {Kwok Kin} and Heymach, {John V.}",

note = "Publisher Copyright: {\textcopyright} Springer Nature America, Inc. 2024.",

year = "2024",

month = sep,

doi = "10.1038/s41591-024-03178-1",

language = "English (US)",

volume = "30",

pages = "2694--2695",

journal = "Nature medicine",

issn = "1078-8956",

publisher = "Nature Research",

number = "9",

}

TY - JOUR

T1 - Correction to

T2 - Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9)

AU - Robichaux, Jacqulyne P.

AU - Elamin, Yasir Y.

AU - Tan, Zhi

AU - Carter, Brett W.

AU - Zhang, Shuxing

AU - Liu, Shengwu

AU - Li, Shuai

AU - Chen, Ting

AU - Poteete, Alissa

AU - Estrada-Bernal, Adriana

AU - Le, Anh T.

AU - Truini, Anna

AU - Nilsson, Monique B.

AU - Sun, Huiying

AU - Roarty, Emily

AU - Goldberg, Sarah B.

AU - Brahmer, Julie R.

AU - Altan, Mehmet

AU - Lu, Charles

AU - Papadimitrakopoulou, Vassiliki

AU - Politi, Katerina

AU - Doebele, Robert C.

AU - Wong, Kwok Kin

AU - Heymach, John V.

PY - 2024/9

Y1 - 2024/9

N2 - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-018-0007-9, published online 23 April 2018. In the version of the article initially published, in Supplementary Fig. 7c, the ERK1/2 blot (afatinib treatment) was flipped with respect to the drug concentration. The corrected version is shown below as Fig. 1. The blots shown in Supplementary Fig. 10d were a repeat of the experiment and have now been corrected to show the membranes that correspond to Supplementary Fig. 7c. The corrected figure is shown below as Fig. 2. (Figure presented.) (Figure presented.)

AB - Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-018-0007-9, published online 23 April 2018. In the version of the article initially published, in Supplementary Fig. 7c, the ERK1/2 blot (afatinib treatment) was flipped with respect to the drug concentration. The corrected version is shown below as Fig. 1. The blots shown in Supplementary Fig. 10d were a repeat of the experiment and have now been corrected to show the membranes that correspond to Supplementary Fig. 7c. The corrected figure is shown below as Fig. 2. (Figure presented.) (Figure presented.)

UR - http://www.scopus.com/inward/record.url?scp=85201683251&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85201683251&partnerID=8YFLogxK

U2 - 10.1038/s41591-024-03178-1

DO - 10.1038/s41591-024-03178-1

M3 - Comment/debate

C2 - 39164519

AN - SCOPUS:85201683251

SN - 1078-8956

VL - 30

SP - 2694

EP - 2695

JO - Nature medicine

JF - Nature medicine

IS - 9

ER -

Correction to: Mechanisms and clinical activity of an EGFR and HER2 exon 20–selective kinase inhibitor in non–small cell lung cancer (Nature Medicine, (2018), 24, 5, (638-646), 10.1038/s41591-018-0007-9)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this